In new defence pleading, Canada couches Eli Lilly case as an unmeritorious denial of justice claim, and also rejects investor’s expropriation claim

You are not logged in. If you are a subscriber, please Login to access. If you are not a subscriber, you can contact us for a rate quote at Alternatively, you can sign up to receive free email headlines here.